Tuesday, October 29, 2013
1:30 - 3:00 pm (EST)
Many food manufacturers use GRAS self-determinations to review food ingredients and to facilitate product reformulation and innovation.
But the process for Generally-Recognized-As-Safe (GRAS) self-determinations is now called into question by members of Congress, the Government Accountability Office (GAO), Pew Charitable Trust, Non-Government Organizations (NGOs), and even FDA. Criticisms of the process range from lack of transparency to concerns regarding an inability of FDA to ensure product safety. FDA itself has expressed that it is often unaware of what ingredients are being used in foods. These recent criticisms have called into question the efficient and effective self-determined GRAS process.
In this pressure-packed environment, many food companies are asking what they need to do to ensure they can continue to use ingredients and additives critical to food product formulations.
GMA’s webinar on Self-determined GRAS is designed to help you keep your food business running smoothly and to help you avoid missteps in ingredient safety assessments. GMA’s webinar will help you understand how to meet regulatory obligations, and will answer some key questions:
Are my records complete and accurate?
- Are my records immediately available for FDA upon their request?
Join us on October 29, 2013 to:
- Hear from FDA, Dr. Antonia Mattia, Division Director of Biotechnology and GRAS Notice Review, what are FDA’s expectations for self-determined GRAS assessments
- Hear from a former FDA Associate Chief Counsel, Mr. Ricardo Carvajal, Hyman, Phelps & McNamara regarding the legal requirements for GRAS self-determination.
Learn the “how-to’s” without having to travel. In just 90 minutes, you will increase your knowledge on how to meet legal requirements and regulatory obligations, learn tips for optimizing your company’s ingredient review processes, and have an opportunity to ask your burning questions about GRAS self-determination.
Audrey Rubio (202) 639-5928